RSCF
Reflect Scientific, Inc.0.0500
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
4.28MP/E (TTM)
-Basic EPS (TTM)
0.00Dividend Yield
0%Recent Filings
10-Q
Q3 FY2024 results
Reflect Scientific posted Q3 revenue of $514K, down 2% y/y yet lifting gross margin to 63.8% from 62.8% on steady freezer and chiller sales. Operating income jumped to $99K (19% margin), driving net income of $110K versus $86K last year, while YTD revenue soared 72% to $1.5M with $157K operating profit against prior loss. Salaries dropped 11% y/y in Q3; inventories fell to $776K. Cash sits at $1.0M, no debt, despite $248K operating cash use from receivables. International sales hit 59% of Q3 revenue. Disclosure controls remain ineffective.
10-Q
Q2 FY2024 results
Reflect Scientific flipped to profitability in Q2 ended June 30, 2024, posting $590k revenue—up 374% y/y from $124k—driven by freezer and chiller sales that lifted gross margin to 60.8% from 48.7%. Operating income hit $98k versus a $181k loss last year, while YTD revenue doubled 179% y/y to $1.0M with $77k net income after a $329k YTD loss prior; EPS aligns at $0.00 on 85.7M shares. Cash dipped to $1.1M after $175k operating outflow from customer deposit timing. Freezers now dominate US revenue. Debt-free. Competition presses harder.
10-Q
Q1 FY2024 results
Reflect Scientific posted Q1 revenue of $428.8k, up 77.8% y/y from $241.1k, fueled by freezer and chiller sales jumping to $264.3k from $45.3k while OEM held steady. Gross margin expanded to 56.4% from 52.9%, yet operating loss narrowed to $40.5k from $147.8k as salaries dropped 12.1%. Other income of $8.5k trimmed net loss to $32k ($0.00 per diluted share on 85.7M shares). Cash fell to $1.1M after $178.5k operating burn. Revenue burns cash. Freezers drive growth, but competition pressures margins.
10-K
FY2023 results
Reflect Scientific's FY2023 revenue plunged 47.1% to $1.08M from $2.04M in 2022, driven by weaker freezer and chiller demand amid customer capex cuts, yielding a $459K net loss versus $89K profit prior year. Gross margins slipped to 55.2% from 59.7% as higher-margin products faded. Operating loss hit $467K on steady salaries but slashed R&D to $30K. Cash dipped to $1.28M, yet working capital stayed solid at $1.77M with no debt. Revenue tanked hard. Four customers made up 35% of sales. Customer concentration risks quarterly momentum.
10-Q
Q3 FY2023 results
Reflect Scientific swung to Q3 operating income of $80,896, up from a $133,220 loss y/y, on revenues doubling 107.7% y/y to $525,874 fueled by freezer and chiller demand while gross margins jumped to 62.8% from 51.7%. Yet YTD revenue fell 42.9% y/y to $891,385, yielding an operating loss of $247,719 as high-margin freezer sales softened earlier. Cash holds steady at $1.3M after $42K operating outflow, beating prior year's $149K burn; no debt. Inventories climbed to $921K. Freezer sales crush it now.
IPO
Employees
Sector
Industry
AVTR
Avantor, Inc.
11.20-0.08
BDX
Becton, Dickinson and Company
196.39-3.70
BIO
Bio-Rad Laboratories, Inc.
302.02-5.90
BLFS
BioLife Solutions, Inc.
24.61-0.04
BSX
Boston Scientific Corporation
92.95+0.76
HBIO
Harvard Bioscience, Inc.
0.70-0.00
RMD
ResMed Inc.
247.34-5.73
RVP
Retractable Technologies, Inc.
0.82-0.01
SCND
Scientific Industries, Inc.
0.55+0.01
TMO
Thermo Fisher Scientific Inc
570.16-5.75